Jefferies Group LLC - IMMUNOMEDICS INC ownership

IMMUNOMEDICS INC's ticker is and the CUSIP is 452907AK4. A total of 12 filers reported holding IMMUNOMEDICS INC in Q3 2016. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
Jefferies Group LLC ownership history of IMMUNOMEDICS INC
ValueSharesWeighting
Q3 2018$16,940,000
-11.3%
4,089,0000.0%0.11%
+3.7%
Q2 2018$19,100,000
+64.8%
4,089,000
+5.1%
0.11%
+72.6%
Q1 2018$11,591,000
-9.0%
3,889,0000.0%0.06%
+3.3%
Q4 2017$12,732,000
+79.3%
3,889,0000.0%0.06%
+27.7%
Q2 2017$7,100,000
+21.3%
3,889,000
-6.6%
0.05%
+6.8%
Q1 2017$5,851,000
+164.0%
4,165,000
+86.4%
0.04%
+266.7%
Q4 2016$2,216,000
-8.0%
2,235,000
-18.3%
0.01%0.0%
Q3 2016$2,409,000
-7.3%
2,735,000
-26.8%
0.01%0.0%
Q2 2016$2,598,000
+439.0%
3,735,000
+422.4%
0.01%
+300.0%
Q1 2016$482,000715,0000.00%
Other shareholders
IMMUNOMEDICS INC shareholders Q3 2016
NameSharesValueWeighting ↓
DLD Asset Management, LP 10,000,000$18,404,0002.40%
Castle Creek Arbitrage, LLC 5,512,000$10,097,0001.08%
Orbimed Advisors 30,000,000$54,794,0000.57%
Graham Capital Management, L.P. 7,000,000$12,833,0000.34%
WOLVERINE ASSET MANAGEMENT LLC 10,010,000$18,308,0000.23%
LAZARD ASSET MANAGEMENT LLC 16,000,000$29,320,0000.06%
Jefferies Group LLC 3,889,000$7,100,0000.05%
PALISADE CAPITAL MANAGEMENT, LP 535,000$982,0000.04%
Paloma Partners Management Co 1,500,000$2,744,0000.03%
Citadel Advisors 12,990,000$23,907,0000.02%
View complete list of IMMUNOMEDICS INC shareholders